Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Tourbillon Capital Partners was a New York-based alternative asset management firm and hedge fund founded by Jason Karp. The firm employed a fundamentally driven long/short equity strategy with low net exposure and sought limited correlation to broader equity markets. Although it invested across sectors and Jason Karp later became active in health and wellness investing through other ventures, Tourbillon Capital Partners itself was not a biotechnology, pharmaceutical, or healthcare operating company. Public records indicate the adviser is no longer currently registered with the SEC, consistent with the firm having ceased active operations.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Tourbillon Capital Partners.